Kanamori A - Search Results

1

Transient reappearance of serum hepatitis C virus RNA observed by real-time PCR during antiviral therapy with peginterferon and ribavirin in patients with HCV genotype 1b.

Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Takagi M, Hiramatsu T, Hosokawa T, Arakawa T, Fujimori M. Toyoda H, et al. Among authors: kanamori a. J Clin Virol. 2010 Mar;47(3):258-62. doi: 10.1016/j.jcv.2009.12.023. Epub 2010 Jan 29. J Clin Virol. 2010. PMID: 20116330

2

Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alpha.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Atsumi H, Takagi M, Nakano S, Arakawa T, Fujimori M. Toyoda H, et al. Among authors: kanamori a. J Med Virol. 2009 Aug;81(8):1354-62. doi: 10.1002/jmv.21533. J Med Virol. 2009. PMID: 19551828

3

Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.

Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Atsumi H, Takagi M, Arakawa T, Fujimori M. Kumada T, et al. Among authors: kanamori a. J Med Virol. 2010 Apr;82(4):539-45. doi: 10.1002/jmv.21686. J Med Virol. 2010. PMID: 20166172

4

An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1.

Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Takagi M, Hiramatsu T, Hosokawa T, Arakawa T, Fujimori M. Toyoda H, et al. Among authors: kanamori a. J Med Virol. 2010 Sep;82(9):1537-44. doi: 10.1002/jmv.21858. J Med Virol. 2010. PMID: 20648607

5

High ability to predict the treatment outcome of peginterferon and ribavirin combination therapy based on the reduction in HCV RNA levels at 4 weeks after starting therapy and amino acid substitutions in the hepatitis C virus in patients infected with HCV genotype 1b.

Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Arakawa T, Fujimori M, Niinomi T, Ando N, Yasuda S, Sakai K, Kimura J. Toyoda H, et al. Among authors: kanamori a. J Gastroenterol. 2011 Apr;46(4):501-9. doi: 10.1007/s00535-010-0328-z. Epub 2010 Oct 7. J Gastroenterol. 2011. PMID: 20927636

6

Outcome in partial early virologic responders to combination therapy with peginterferon and ribavirin in patients infected with hepatitis C virus genotype 1b.

Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Hosokawa T, Arakawa T, Fujimori M. Toyoda H, et al. Among authors: kanamori a. J Med Virol. 2011 Jan;83(1):101-7. doi: 10.1002/jmv.21936. J Med Virol. 2011. PMID: 21108345

7

Association between hepatic steatosis and hepatic expression of genes involved in innate immunity in patients with chronic hepatitis C.

Toyoda H, Kumada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Tada T, Kitabatake S, Murakami Y. Toyoda H, et al. Among authors: kanamori a. Cytokine. 2013 Aug;63(2):145-50. doi: 10.1016/j.cyto.2013.04.012. Epub 2013 May 11. Cytokine. 2013. PMID: 23673288

8

Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection.

Toyoda H, Kumada T, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Ito T. Toyoda H, et al. Among authors: kanamori a. J Gastroenterol Hepatol. 2015 Jul;30(7):1183-9. doi: 10.1111/jgh.12915. J Gastroenterol Hepatol. 2015. PMID: 25678094

9

Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.

Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Yama T, Tanaka J. Tada T, et al. Among authors: kanamori a. Liver Int. 2016 Jun;36(6):817-26. doi: 10.1111/liv.13071. Epub 2016 Feb 12. Liver Int. 2016. PMID: 26787002

10

Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.

Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Yama T, Tanaka J. Tada T, et al. Among authors: kanamori a. J Gastroenterol Hepatol. 2017 Mar;32(3):687-694. doi: 10.1111/jgh.13589. J Gastroenterol Hepatol. 2017. PMID: 27577675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters